Ocrelizumab
(asked on )
Question to the Ministry of Defence:
To ask the Secretary of State for Defence, what recent assessment he has made of the (a) associated costs and (b) utility of the Trident Alternatives Review.
This question was answered on 28th April 2014
I have made no such assessment.